SEC Comment Letter 0000000000-23-011404 to OSR Health, Inc. (OSRH)

OSR Health, Inc.
Date: Oct. 18, 2023 · CIK: 0001840425 · Accession: 0000000000-23-011404

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 001-41390

Date

October 18, 2023

Author

Not clearly detected

Form

UPLOAD

Company

OSR Health, Inc.

Letter

United States securities and exchange commission logo October 18, 2023 Kuk Hyoun Hwang Chief Executive Officer Bellevue Life Sciences Acquisition Corp. 10900 NE 4th Street Suite 2300 Bellevue, WA 98004 Re:Bellevue Life Sciences Acquisition Corp. Preliminary Proxy Statement on Schedule 14A Filed October 10, 2023 File No. 001-41390 Dear Kuk Hyoun Hwang: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Real Estate & Construction cc: Gary Kocher, Esq.

Show Raw Text

United States securities and exchange commission logo
October 18, 2023
Kuk Hyoun Hwang
Chief Executive Officer
Bellevue Life Sciences Acquisition Corp.
10900 NE 4th Street
Suite 2300
Bellevue, WA 98004
Re:Bellevue Life Sciences Acquisition Corp.
Preliminary Proxy Statement on Schedule 14A
Filed October 10, 2023
File No. 001-41390
Dear Kuk Hyoun Hwang:
            We have completed our review of your filing. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Real Estate & Construction
cc:       Gary Kocher, Esq.

SecProbe.io